Indian Journal of Pharmaceutical Education and Research logo
Submit
Indian Journal of Pharmaceutical Education and ResearchAn Official Publication of Association of Pharmaceutical Teachers of India (APTI)
Article

Pharmacovigilance Programme of India: System put in place to Report Adverse Drug Reactions

1, 1, 2, 1

  1. 1Indian Pharmacopoeia Commission, Ministry of Health & Family Welfare, Govt of India, Sector 23, Rajnagar, Ghaziabad, U.P.-201002, India.
  2. 2National Institute of Biologics (NIB), Ministry of Health & Family Welfare, Govt.of India, Plot No. A-32, Sector-62, Institutional Area, NOIDA, U.P.-201 309, India.

CORRESPONDENCE

Ismeet Kaur

Indian Pharmacopoeia Commission, Ministry of Health & Family Welfare, Govt of India, Sector 23, Rajnagar, Ghaziabad, U.P.-201002, India.

ishunarang12@gmail.com

Received: 03-12-2014; Accepted: 19-07-2015.

Volume 50, Issue 1 · pp. 212-214 · 2016 · DOI: 10.5530/ijper.50.1.26

ABSTRACT

Adverse drug reaction (ADRs) is response to a drug which is noxious and unintended and which occurs at doses normally used in human for the prophylaxis, diagnosis or treatment of disease, or for the modification of physiological function.1 ADRs are one of the major public health issues and found to cause of morbidity and mortality.2 The impact of ADRs in India is significant and leads to the enormous burden to the public. Therefore, Ministry of Health & Family Welfare (MoHFW), Government of India launched a nationwide Pharmacovigilance Programme of India (PvPI) in the year 2010 to monitor the safety of drugs. Indian Pharmacopoeia Commission (IPC) under the MoHFW functions as National Coordination Centre (NCC) for PvPI. To monitor and report ADRs to NCC, teaching hospitals and corporate hospitals have been identified as ADRs Monitoring Centres (AMCs).

KEYWORDS

Open in new tab

REFERENCES

As published

Showing references and in-text citations exactly as published.

    Cite this article

    SELECT FORMAT

    Kalaiselvan, V., Kaur, I., Singh, S., & Singh, G. N. (2016). Pharmacovigilance Programme of India: System put in place to Report Adverse Drug Reactions. Indian Journal of Pharmaceutical Education and Research, 50(1), 212-214. https://doi.org/10.5530/ijper.50.1.26

    Copyright and licence

    © 2016 Author(s)

    This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited. CC BY 4.0